75 min listen
Sequencing Of Agents
FromAUAUniversity
ratings:
Length:
33 minutes
Released:
Sep 25, 2024
Format:
Podcast episode
Description
Sequencing Of Agents
CME Available: https://auau.auanet.org/node/41735
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
Lantheus Medical Imaging
Novartis Pharmaceuticals Corporation
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Review the latest evidence and clinical guidelines that inform the sequencing of therapeutic agents in metastatic prostate cancer, including data from key clinical trials.
3. Implement strategies for managing and overcoming resistance to therapy in metastatic prostate cancer, considering the role of sequencing in delaying resistance.
4. Apply best practices for monitoring treatment response and disease progression in patients undergoing therapy, and adjust sequencing strategies based on these observations.
CME Available: https://auau.auanet.org/node/41735
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
Lantheus Medical Imaging
Novartis Pharmaceuticals Corporation
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Review the latest evidence and clinical guidelines that inform the sequencing of therapeutic agents in metastatic prostate cancer, including data from key clinical trials.
3. Implement strategies for managing and overcoming resistance to therapy in metastatic prostate cancer, considering the role of sequencing in delaying resistance.
4. Apply best practices for monitoring treatment response and disease progression in patients undergoing therapy, and adjust sequencing strategies based on these observations.
Released:
Sep 25, 2024
Format:
Podcast episode
Titles in the series (63)
Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice: Incorporating the AUA/SUO Guideline on Advanced P… by AUAUniversity